（文章来源：证券日报） 证券日报网讯 1月13日，华新精科在互动平台回答投资者提问时表示，公司股价表现受宏观经济、行业 政策、市场情绪等多重因素影响，并非单一业务指标所能决定。公司自上市以来一直高度重视市值管理 工作，并严格按照相关法律法规及公司章程的规定，持续提升公司经营管理水平。公司将持续密切关注 市场反馈，不断优化经营策略，以稳健业绩为基础，努力为股东创造长期价值，同时严格遵循信息披露 准则，及时、准确、完整地向市场传递最新动态。 ...

现场检查报告 华泰联合证券有限责任公司 关于江阴华新精密科技股份有限公司 2025 年度现场检查报告 根据中国证监会《证券发行上市保荐业务管理办法》和《上海证券交易所上 市公司自律监管指引第 11 号——持续督导》等有关法律法规的要求，华泰联合 证券有限责任公司（以下简称华泰联合证券）作为江阴华新精密科技股份有限公 司（以下简称华新精科或公司）首次公开发行股票的保荐机构，于 2026 年 1 月 7 日至 1 月 8 日对江阴华新精密科技股份有限公司 2025 年度持续督导期间（2025 年 9 月 5 日至 2025 年 12 月 31 日）内有关情况进行了现场检查。 一、本次现场检查的基本情况 华泰联合证券针对华新精科实际情况制订了 2025 年度现场检查工作计划。 为顺利实施本次现场工作，提高现场工作效率，切实履行持续督导工作，华泰联 合证券于 2026 年 1 月 5 日以邮件方式将现场检查事宜通知华新精科，并要求公 司提前准备现场检查工作所需的相关文件和资料。 2026 年 1 月 7 日至 8 日，华泰联合证券保荐代表人根据事先制订的现场检 查工作计划，采取访谈、实地查看、查阅有关资料等形式，对公 ...

证券代码：603370 证券简称：华新精科 公告编号：2026-001 江阴华新精密科技股份有限公司 2026年第一次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 261 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 131,683,240 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股份总数的 | | | 比例（%） | 75.2690 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 本次股东会由公司董事会召集，现场会议由公司董事长郭正平先生主持。会 议的召集和召开程序、表决方式均符合《公司法》及《公司章程》的有关规定。 (五) 公司董事和董事会秘书的列席情况 1、公司在任董事9人，列席9人； 2、公司董事会秘书列席会议，公司高级管理人员列 ...

（2026）康达（苏）法意第 12007 号 江苏省苏州市工业园区九章路 69 号理想创新大厦 A 幢 12 层 12 / F, Building A, Ideal Innovation Building, No. 69, Jiuzhang Road, Suzhou Industrial Park, Jiangsu Province 邮编/Zip Code:215000 电话/Tel:86-0512-67586952 传真/Fax:86-0512-67586972 电子邮箱/E-mail： kangda@kangdalawyers.com 北京 西安 深圳 海口 上海 广州 杭州 沈阳 南京 天津 菏泽 成都 苏州 呼和浩特 香港 武汉 郑州 长沙 厦门 重庆 合肥 宁波 济南 昆明 南昌 北京市康达（苏州）律师事务所 关于江阴华新精密科技股份有限公司 2026 年第一次临时股东会的 法 律 意 见 书 致：江阴华新精密科技股份有限公司 北京市康达（苏州）律师事务所（以下简称"本所"）接受江阴华新精密科技股份 有限公司（以下简称"公司"）的委托，指派本所律师参加公司 2026 年第一次临时股东 会（以下简称" ...

Core Viewpoint - Huaxin Jingke announced the approval of a proposal to use idle self-owned funds for entrusted wealth management during the tenth meeting of the fourth board of directors [2] Group 1 - The board of directors approved the proposal on December 30 [2]

Group 1 - China Medical plans to acquire 70% equity of Zezheng Pharmaceutical for 525 million yuan to enhance its R&D capabilities in the pharmaceutical sector [1] - Hongchang Electronics has commenced production of its functional high-end copper-clad laminate electronic materials project [2] - China State Construction has secured multiple major projects totaling 32.09 billion yuan, which represents 1.5% of its audited revenue for 2024 [3] Group 2 - China Resources Double Crane has established an industrial fund with a committed investment of 83 million yuan, targeting a total fundraising goal of 500 million yuan [4] - Pinggao Electric and its subsidiaries have won state grid procurement projects worth approximately 876 million yuan, accounting for 7.06% of its 2024 revenue [5] - Dong'an Power received a government subsidy of 2.47 million yuan, with 1.47 million yuan related to assets and 1 million yuan related to income [6] Group 3 - Nantian Information has paid overdue taxes and penalties totaling 50.31 million yuan, which will impact its net profit for 2025 [7] - Erli Six has changed its investment plan to establish a wholly-owned subsidiary in Hong Kong for submarine cable business with an investment of 320 million yuan [8] - Dream Lily plans to invest 170 million yuan in an e-commerce warehouse project at its East US factory [9] Group 4 - Shen Shen Fang A's controlling shareholder has terminated the agreement to transfer 7.07% of the company's shares to Dongfang Asset, with no change in control [10] - Tianfu Culture has signed strategic cooperation framework agreements with various cultural and tourism bureaus to promote film and tourism integration [11] - Jinzi Tianzheng's chairman has resigned due to work adjustments, but will continue to fulfill his duties until a new chairman is elected [12] Group 5 - Jiangshan Oupai and its subsidiaries received government subsidies totaling 10.04 million yuan, with 7.51 million yuan related to income [13] - Ninghu Expressway plans to increase its investment in Jiangsu Danjin Expressway Co., Ltd. by 128 million yuan to support highway construction [14] - Jiangyin Bank has received approval for the qualifications of its employee director and vice president [15] Group 6 - Aoxiang Pharmaceutical has received approval for the listing application of two chemical raw materials [16] - Daye Co. has not yet commenced mass production of its robotic tendon products, with ongoing uncertainties in technology and profitability [17] - Rongsheng Environmental has proposed a cash dividend of 3.8 yuan per 10 shares, totaling approximately 97.36 million yuan [19] Group 7 - Yunyi Electric plans to invest 66 million USD in Morocco to establish a wholly-owned subsidiary and production base [20] - Derun Electronics has reached an agreement regarding the delayed payment of 100 million yuan in equity transfer funds [21] - Baihua Pharmaceutical is planning a change in control, leading to a continued suspension of its stock [22] Group 8 - CITIC Bank's executive director and president has resigned due to work adjustments [23] - Haizike's subsidiary has received acceptance for clinical trial applications for two innovative drugs [24] - Tianrun Dairy's subsidiaries received government subsidies totaling 21.53 million yuan, representing 49.32% of its net profit for 2024 [25] Group 9 - Andisou plans to issue 398 million A-shares at 7.54 yuan per share, raising a total of 3 billion yuan [26][27] - Fuda Co. has completed the transfer of its 50% stake in a joint venture, which is expected to positively impact its 2025 financial results [28] - Jianghua Micro has received environmental approval for a project to produce 37,000 tons of ultra-pure wet electronic chemicals [29] Group 10 - Nanwang Technology received a government subsidy of 10 million yuan, accounting for 0.66% of its net assets for 2024 [30] - Changgao Electric New has won state grid procurement projects totaling 161 million yuan, representing 9.14% of its 2024 revenue [31] - Huaxin Precision plans to invest up to 600 million yuan of idle funds in low-risk financial products [32] Group 11 - Fuguang Co. received a government subsidy of 1.26 million yuan for basic research projects, which is 13.27% of its net profit for 2024 [33] - Benli Technology has obtained a drug production license, which will help optimize its product structure [34] - Jintuo Co. proposed a cash dividend of 4.1 yuan per 10 shares, totaling approximately 99.48 million yuan [35] Group 12 - Kang Enbei has elected a new chairman and vice chairman during its board meeting [36] - Sanyuan Bio has completed the construction and installation of equipment for the remaining capacity of its 20,000-ton alulose project [38]

基本情况 | 投资金额 | 不超过人民币 亿元 6.00 | | --- | --- | | 投资种类 | 安全性高、流动性好的中低风险理财产品 | | 资金来源 | 自有资金 | 证券代码：603370 证券简称：华新精科 公告编号：2025-021 江阴华新精密科技股份有限公司关于 使用闲置自有资金进行委托理财的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 已履行及拟履行的审议程序 （二）投资金额 江阴华新精密科技股份有限公司（以下简称"公司"）于 2025 年 12 月 30 日召开第四届董事会第十次会议，审议通过了《关于公司使用闲置自有资金进行 委托理财的议案》，该事项在董事会审批权限范围内，无需提交公司股东会审议。 特别风险提示 公司拟使用闲置自有资金购买安全性高、流动性好的中低风险理财产品，但 金融市场受宏观经济的影响较大，不排除该项投资受到市场波动风险、宏观经济 形势及货币政策、财政政策等宏观政策发生变化带来的系统性风险影响。 一、投资情况概述 （一）投资目的 为提高公司闲置自有资金使用效 ...

江阴华新精密科技股份有限公司 2026 年第一次临时股东会会议资料 2026 年第一次临时股东会会议须知 为了维护投资者的合法权益，确保股东在本公司 2026 年第一次临时股东会 期间依法行使权利，保证股东会的正常秩序和议事效率，依据中国证券监督管理 委员会《上市公司股东会规则》的有关规定，本次股东会须知如下： 一、股东会召开当日，出席会议的股东及股东代理人须在会议召开前 30 分 钟到会议现场办理签到手续。 1、个人股东亲自出席会议的，应出示本人身份证或其他能够表明其身份的 有效证件或证明；委托代理他人出席会议的，应出示本人有效身份证件、股东授 权委托书。 江阴华新精密科技股份有限公司 2026 年第一次临时股东会会议资料 江阴华新精密科技股份有限公司 （证券代码：603370） 2026 年第一次临时股东会会议资料 二零二六年一月 2、非自然人股东应由其法定代表人/合伙企业执行事务合伙人（或其委派代 表）或者法定代表人/合伙企业执行事务合伙人（或其委派代表）委托的代理人 出席会议。法定代表人/合伙企业执行事务合伙人（或其委派代表）出席会议的， 应出示本人身份证明、能证明其具有法定代表人/合伙企业执行事务合 ...

证券代码：603370 证券简称：华新精科 公告编号：2025-020 江阴华新精密科技股份有限公司 第四届董事会第十次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 与会董事审议通过了以下议案： 1、审议通过《关于公司使用闲置自有资金进行委托理财的议案》； 同意：9 票，反对：0 票，弃权：0 票。 相关内容请查阅公司在上海证券交易所网站（www.sse.com.cn）披露的《关 于公司使用闲置自有资金进行委托理财的公告》(公告编号：2025-021）。 特此公告。 江阴华新精密科技股份有限公司董事会 2025 年 12 月 31 日 1 江阴华新精密科技股份有限公司（以下简称"公司"）第四届董事会第十次 会议通知和文件于 2025 年 12 月 25 日以电话、邮件方式送达，会议于 2025 年 12 月 30 日在公司会议室以现场结合通讯的方式召开。会议应出席董事 9 人，实 际出席董事 9 人。会议由董事长郭正平先生召集并主持，公司高级管理人员列席 会议。本次会议的召集、召开及表决 ...

Core Viewpoint - The company plans to use up to 600 million yuan of idle self-owned funds for entrusted wealth management, focusing on low to medium-risk financial products with high safety and liquidity [1] Group 1: Financial Decision - The fourth board meeting will be held on December 30, 2025, to approve the investment proposal [1] - The investment period will start from the date of the board meeting approval until 2026 [1] - The funds can be used in a rolling manner within the approved limit and validity period [1] Group 2: Risk Management - The company acknowledges that investments may be affected by market fluctuations and systemic risks [1] - Corresponding risk control measures have been established to mitigate potential impacts [1]